In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus

ABSTRACT: Hepatitis E virus (HEV) infection is emerging in Cameroon and represents one of the most common causes of acute hepatitis and jaundice. Moreover, earlier reports showed evidence of falciparum malaria/HEVcoexistence. Although the Sofosbuvir/Ribavirin combination was recently proposed in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tietcheu Galani, Borris Rosnay, Ayissi Owona, Vincent Brice, Guemmogne Temdie, Romeo Joel, Metzger, Karoline, Atsama Amougou, Marie, Djamen Chuisseu, Pascal Dieudonné, Fondjo Kouam, Arnaud, Ngounoue Djuidje, Marceline, Aliouat-Denis, Cécile-Marie, Cocquerel, Laurence, Fewou Moundipa, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093904/
https://www.ncbi.nlm.nih.gov/pubmed/33959472
http://dx.doi.org/10.1007/s40203-021-00093-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093904/
https://www.ncbi.nlm.nih.gov/pubmed/33959472
http://dx.doi.org/10.1007/s40203-021-00093-y

Ejemplares similares